Market reporting

Listen to this article on the DDW Podcast: As part of the Fall Issue of DDW’s Market Report, DDW Editor Lu Rahman explores the Chinese pharmaceutical landscape and what the new era of drug discovery is starting to look like in the country. China has a population of more than 1.4 billion people. Figures from the latest population […]

Listen to this article on the DDW Podcast: As part of the Fall Issue of DDW’s Market Report, Sy Chyi Yeoh, Director of Business Development at global regulatory service provider ELC Group, explains why the biotech sector in China is worth watching and offers advice for those keen to take advantage.  Pharmaceutical firms from China are […]

DDW’s Editor Lu Rahman comments and gives perspective on the global drug discovery and development market in the UK. As I’m writing this in the UK, there are reports of gas supply shortages, a lack of CO2­ affecting food supply, the price of energy is rising and the cherry on top – murmurings of cancelling […]

A report by Fact.MR reveals that the global antibacterial drugs market is projected to grow at a modest CAGR of 2.6% during the forecast period (2021-2031), expected to reach a value of US$62 billion. In the short run, the market is poised to expand at a CAGR of 1.5% from 2020-2025 to reach US$50 billion.  […]

The “CRISPR Based Therapeutics Market by Type of Therapy, Therapeutic Approach, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global Forecasts 2021-2030” report has been added to ResearchAndMarkets.com’s offering.  The report features a study of the current market landscape and future opportunity for the players involved in the development of CRISPR based therapeutics for the treatment […]

Listen to this article on the DDW Podcast: Lu Rahman introduces a slice of European biotech expertise Thanks to the Covid-19 pandemic, the global biotech sector has been thrown into the spotlight, not just in the drug discovery and development word, but as a sector that the general public has come to know more closely, and […]

A post-pandemic pharma report from CPhI predicts the next few years will deliver strong growth in pharma innovation, with oncology and rare diseases potentially the biggest beneficiaries of positive Covid-19 legacies – including accelerated development timelines, remote trials and new technologies in genetic and target screening. The report anticipates breakthroughs in multi-modal disease therapies within five […]